Kintayl Capital »

Catalyst Pharmaceutical Partners shares owned by Kintayl Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Kintayl Capital from 13F filings

Historical chart of Kintayl Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Kintayl Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Kintayl Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 114k 31.43

More positions owned by Kintayl Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Essential Utils (WTRG)
Ncr Atleos Corporation Com Shs (NATL)
Silicon Laboratories (SLAB)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Allied Gold Corp Com New (AAUC)
Electronic Arts (EA)
Orla Mining LTD New F (ORLA)
Dominion Resources (D)
AvalonBay Communities (AVB)
Kenvue (KVUE)
Valaris Cl A (VAL)
AES Corporation (AES)
Northwestern Energy Group In Com New (NWE)
Equitable Holdings (EQH)

View all positions for Kintayl Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners